These include adjusting the dose of diuretics based on serum CA125 levels, increasing the number of outpatient visits, administering intravenous iron in patients with iron deficiency, upregulating of statins in those with high serum CA125 levels, and initiating mineralocorticoid antagonists, with the goal of maintaining serum CA125 levels below 35 U/ml. The gene discussed is MUC16; the disease is Iron deficiency anemia.